4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brueggen, J; Friedlos, F; Marais, R; Matter, A; Maycroft, K; O'Reilly, T; Roussel, J; Spooner, RA; Springer, CJ; Stolz, B; Stribbling, SM; Wood, J | 1 |
| Boden, JA; Martin, J; Pedley, RB; Sharma, SK; Springer, CJ; Stribbling, SM | 1 |
2 other study(ies) available for 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid and Adenocarcinoma
| Article | Year |
|---|---|
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs.
Topics: Adenocarcinoma; Endothelial Growth Factors; Endothelium; Female; gamma-Glutamyl Hydrolase; Glutamates; Glutamine; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Nitrogen Mustard Compounds; Ovarian Neoplasms; Plasmids; Point Mutation; Prodrugs; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2003 |
Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoembryonic Antigen; Chromatography, High Pressure Liquid; Colonic Neoplasms; Female; gamma-Glutamyl Hydrolase; Glutamates; Immunoconjugates; Mice; Mice, Nude; Nitrogen Mustard Compounds; Prodrugs; Tissue Distribution; Transplantation, Heterologous | 1997 |